Guardant Health
GH
#3559
Rank
S$4.02 B
Marketcap
$32.68
Share price
-1.18%
Change (1 day)
-12.81%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of June 2024 : -S$2.11 M

According to Guardant Health 's latest financial reports the company has -S$2.11 M in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$S$0.20 B159.77%
2022-12-31$S$80.67 M-90.73%
2021-12-31$S$0.86 B-51.46%
2020-12-31$S$1.79 B57.16%
2019-12-31$S$1.14 B59.46%
2018-12-31$S$0.71 B73.25%
2017-12-31$S$0.41 B257.85%
2016-12-31$S$0.11 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$1.08 B-51,961.13%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.09 B-195,024.98%๐Ÿ‡บ๐Ÿ‡ธ USA